Sign up to save your podcasts
Or
Share Novel & Innovative Therapeutics - Thomas Collet, PhD & Robert Langer, SCD - Bilayer Therapeutics
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Novel & Innovative Therapeutics - Thomas Collet, PhD & Robert Langer, SCD - Bilayer Therapeutics
Learn from Thomas Collet, PhD, Bilayer Therapeutics - President & CEO; and Robert Langer, SCD
Bilayer Therapeutics - Director & Scientific Advisor, MIT, about how the company is creating first-in-class therapies for gastrointestinal disease and metabolic disorders.
Bilayer Therapeutics
https://bilayer-therapeutics.com
Hosted by Steven Saltzstein, CEO, FORCE Family Office:
https://forcefamilyoffice.com
View all episodes
By Steven SaltzsteinLearn from Thomas Collet, PhD, Bilayer Therapeutics - President & CEO; and Robert Langer, SCD
Bilayer Therapeutics - Director & Scientific Advisor, MIT, about how the company is creating first-in-class therapies for gastrointestinal disease and metabolic disorders.
Bilayer Therapeutics
https://bilayer-therapeutics.com
Hosted by Steven Saltzstein, CEO, FORCE Family Office:
https://forcefamilyoffice.com